🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
At present, there is no standard second-line treatment of refractory and re...
Status
Unknown
Location
he First Affiliated Hospital of Guangzhou Medical College
Start Date
2012-10
Trial ID
NCT01872416
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Lund University Hospital
Start Date
1996-04
Trial ID
NCT00002764
Treatments Being Tested
Apatinib mesylate is a multitarget receptor tyrosine kinase inhibitor. This...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-08-20
Trial ID
NCT04012827
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This randomized phase II/III trial studies how well pazopanib, when combine...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2014-08-12
Trial ID
NCT02180867
The goal of this clinical research study is to find the highest safe dose o...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-08
Trial ID
NCT00147225
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Institut Sainte Catherine
Start Date
1998-03
Trial ID
NCT00003683
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
Royal Victoria Infirmary
Start Date
1992-07
Trial ID
NCT00002516
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Nottingham City Hospital
Start Date
2006-01
Trial ID
NCT00974792
Ridaforolimus has been tested in almost 2 dozen studies; however, it has no...
Status
Withdrawn
Location
Cancer Therapy & Research Center at UTHSCSA
Start Date
2011-02
Trial ID
NCT01296659
Treatments Being Tested